The Cancer Support Community (CSC) and Carevive are partnering to provide an innovative nursing and social work team-based care delivery model to health systems across the U.S.
Multiple clinical trials have demonstrated benefits of symptom monitoring using patient-reported outcomes during systemic cancer therapy. This care enhancement generally includes software that prompts patients to self-report their symptoms on a regular basis via a survey, using a computer or connected device (e.g., weekly). Severe or worsening symptoms trigger alert notifications to the care team to react and manage concerning…
CMS’ Center for Medicare and Medicaid Innovation recently bid adieu to its voluntary, performance-based Oncology Care Model (OCM) and announced the launch of it’s next generation cancer value-based program—the Enhancing Oncology Model (EOM) — scheduled to begin on July 1, 2023. Over its six-year run beginning in 2016, the OCM fell short of its Medicare cost-savings expectations but set in…
April Boyd, Sr. Clinical Content Developer at Carevive, is a nurse with many years of oncology experience. Boyd understands what it takes to achieve better patient outcomes. She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston.
Join us for the following Peer-to-Peer Discussions on the Enhanced Oncology Model (EOM) on August 10 at 2pm ET and August 26 at 11am ET, featuring successful OCM site thought leaders. The Centers for Medicare & Medicaid Service (CMS) intends to increase the standard of care for cancer patients while lowering costs.
Gynecologic Cancers by the numbers. In this infographic, we'd like to highlight some important facts and figures on gynecologic cancers as well as key learnings from Carevive SMART Data™.
A career change can often come with uncertainty for the future, but for Christina Morgan, Clinical Practice Transformation Advisor at Carevive, it gave her a voice to advocate for cancer patients helping them receive the highest quality of care. Oncology and Technology host Tyler Kern sat with Morgan to discuss her transition from the field of nursing to clinical practice.
Acute myeloid leukemia (AML) by numbers. In this infographic, we'd like to highlight some important facts and figures on AML as well as key learnings from Carevive SMART Data™.
Overall results demonstrate the feasibility of gathering patient perspectives such as QoL preference, perceptions of durability, and treatment concerns in routine practice.
The objective of this study is to characterize initial treatment burden in oncology patients, by assessing health resource utilization (HRU) and dose modification, with and without active symptom monitoring.